Serum free light chain assay to detect low grade plasma-cell dyscrasia. - Mass spectrometry for unambiguous and reliable typing of amyloid. N-terminal probrain natriuretic peptide and troponin for ...

Dr. Douglas Sborov, myeloma clinician and researcher Dr. Douglas Sborov is the Director of the Hematology Disease Center and the Plasma Cell Dyscrasias Program at the Huntsman Cancer Institute, ...

Differential diagnosis in this patient with extreme hypercalcaemia included solid-organ malignancies with metastatic disease, plasma cell dyscrasia (multiple myeloma), primary hyperparathyroidism ...

A new research paper was published in , Volume 16, on March 21, 2025, titled "NSD2-epigenomic reprogramming and maintenance of plasma cell phenotype in t(4;14) myeloma." ...

The study in the European Respiratory Journal used advanced spatial mapping techniques to compare healthy lung tissues and ...

Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

Plasma cells originate in lymphoid (immune) tissues and then migrate to protected sites throughout the body, where they produce large amounts of antibodies in response to infection-related substances.

The researchers discovered that disease-scarred lung tissue abounds in plasma cells -- specialized immune cells that typically reside in bone marrow and produce antibodies. "What we found most ...

In patients experiencing excessive bleeding during cardiac surgery, a concentrated blood product containing proteins that ...

For the first time, scientists have 'photographed' a rare plasma instability, where high-energy electron beams form into spaghetti-like filaments. A new study, published in Physical Review Letters ...

Mar. 11, 2025 — Researchers have identified genetic changes in blood stem cells from frequent blood donors that support the production of new, non-cancerous cells. Understanding the differences ...